Plain-English translation of NCT06867289 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether brain wave monitoring (EEG) can help doctors determine if a child needs a higher dose of dexmedetomidine — a sedative medication given through the nose — to successfully complete a brain MRI scan. Currently, some children don't respond well to the standard dose, and doctors have to either delay the scan or use general anesthesia instead. The study hopes that brain wave readings during the scan can identify which children need more medication, making the procedure safer and more successful.
Brain MRI scans are very important for diagnosing and monitoring brain conditions in children, but many young children can't stay still long enough without sedation. The current medication sometimes doesn't work well enough—it fails about 20–30% of the time. This trial aims to find a better way to predict which children need a stronger dose before the scan fails, avoiding delays and the need for deeper, riskier anesthesia.
You likely qualify if…
You likely don't qualify if…
Your child will receive the sedation medication through the nose as planned for their brain scan. During the scan, the doctors will also place sensors on your child's head to monitor brain wave activity (EEG), which helps them see how well the sedation is working. The EEG monitoring is in addition to the usual care and safety checks. The goal is to understand whether the brain wave pattern can predict whether your child needs a higher dose of medication to complete the scan safely.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
France